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Abstract
Background: Most adult intensive care units (ICUs) worldwide adopt restrictive family visitation models (RFVMs).
However, evidence, mostly from non-randomized studies, suggests that flexible adult ICU visiting hours are safe
policies that can result in benefits such as prevention of delirium and increase in satisfaction with care. Accordingly,
the ICU Visits Study was designed to compare the effectiveness and safety of a flexible family visitation model
(FFVM) vs. an RFVM on delirium prevention among ICU patients, and also to analyze its potential effects on family
members and ICU professionals.
Methods/design: The ICU Visits Study is a cluster-randomized crossover trial which compares an FFVM (12
consecutive ICU visiting hours per day) with an RFVM (< 4.5 ICU visiting hours per day) in 40 Brazilian adult ICUs.
Participant ICUs are randomly assigned to either an FFVM or RFVM in a 1:1 ratio. After enrollment and follow-up of
25 patients, each ICU is crossed over to the other visitation model, until 25 more patients per site are enrolled and
followed. The primary outcome is the cumulative incidence of delirium measured by the Confusion Assessment
Method for the ICU. Secondary and tertiary outcomes include relevant measures of effectiveness and safety of ICU
visiting policies among patients, family members, and ICU professionals. Herein, we describe all primary statistical
procedures that will be used to evaluate the results and perform exploratory and sensitivity analyses of this study.
This pre-specified statistical analysis plan was written and submitted without knowledge of the study data.
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Discussion: This a priori statistical analysis plan aims to enhance the transparency of our study, facilitating unbiased
analyses of ICU visit study data, and provide guidance for statistical analysis for groups conducting studies in the
same field.
Trial registration: ClinicalTrials.gov, NCT02932358. Registered on 11 October 2016.
Keywords: Critical care, Delirium, Cross infection, Family, Personal satisfaction, Anxiety, Depression, Health
personnel, Burnout
Background
The recognition of the important role of family members
in the intensive care unit (ICU) is the cornerstone of
patient-centered care [1]. Beyond the justification of
humanization, this strategy is proposed as a means to
improve patient and family member outcomes [2]. In
this context, small studies with a predominant before
and after design have shown an association between
flexible ICU visiting hours and reduced incidence of de-
lirium in patients and increased satisfaction with care in
family members [3–5]. Despite the growing recognition
of the importance of family presence in the ICU, most
ICUs around the world still adopt restricted visiting
hours motivated by the ICU professionals’ perceptions
of increased risk of disorganization of care, infection
transmission, and burnout [6–9]. Unfortunately, few ran-
domized studies have focused on the evaluation of the
impact of different ICU visiting models on patients, fam-
ily members, and ICU professionals, and this lack of evi-
dence may constitute a barrier to the implementation of
patient-centered care interventions in the ICU. The ICU
Visits Study aims to investigate the effectiveness and
safety of a flexible family visitation model (FFVM) vs. a
restrictive family visitation model (RFVM) on delirium
prevention among ICU patients, and to evaluate its po-
tential benefits and hazards for family members and
ICU professionals.
The present statistical analysis plan (SAP) aims to de-
scribe the trial’s analytical objectives and procedures
before the end of the study recruitment and locking of
the trial database to start analyses to comply with good
clinical practice and avoid outcome reporting bias. This
SAP was drafted without knowledge of any of the results
of the investigators.
Trial overview
The ICU Visits Study is a cluster-randomized, crossover
trial comparing an FFVM (12 consecutive ICU visiting
hours per day) with an RFVM (< 4.5 ICU visiting hours
per day) in Brazilian adult ICUs. The study background,
design, rationale, eligibility criteria, and sample size have
been previously published [10]. In brief, mixed adult
ICUs of public and private philanthropic hospitals with a
restrictive policy of ICU visiting hours (< 4.5 h/day) are
randomly assigned to either an FFVM or RFVM in a 1:1
ratio until the recruitment and follow-up of 25 patients
(phase 1) (Fig. 1). After a 30-day washout period without
subject recruitment, each ICU is switched over to the
other visitation model (phase 2) until 25 more patients
per site are enrolled and followed. The randomization is
stratified by the number of ICU beds (1 to 10 or > 10
ICU beds) and performed using random block sizes of 2,
4, and 6. Consecutive patients aged ≥18 years admitted
to the ICU, their closest family members, and bedside
ICU professionals in each cluster are considered eligible
for the present trial. A complete description of the inclu-
sion and exclusion criteria is shown in Table 1.
In the FFVM, patients are allowed to receive visits
from one or two close family members for up to 12
consecutive hours each day. Family members who
agree to join the family visits have to attend a struc-
tured meeting at the ICU in which they receive guid-
ance about the ICU environment, common ICU
treatments, rehabilitation and basic infection control
practices, multidisciplinary work at the ICU, and in-
formation on palliative care and delirium prevention.
Additionally, family members receive an information
brochure and are encouraged to access a website,
both of which are designed to explain what happens
during and after an ICU stay to legitimize emotions
and improve cooperation with relatives without in-
creasing the ICU staff workload. In addition to family
visitation, patients in the FFVM are allowed to
receive social visits at specific time intervals (accord-
ing to the local ICU policies) from friends or other
family members who did not qualify for flexible fam-
ily visitation. In the RFVM, patients are allowed visi-
tors according to routine ICU practices, but limited
to the maximum of 4.5 h of visitation per day. Visi-
tors are not required to attend the structured meeting
in the RFVM.
The study primary outcome is the cumulative incidence
of delirium during the ICU stay measured by trained re-
searchers using the Confusion Assessment Method for the
ICU (CAM-ICU) [11]. Secondary outcomes include daily
hazard of delirium, ventilator-free days at day 7, any
ICU-acquired infections according to the Centers for Dis-
ease Control and Prevention (CDC) criteria [12–14], ICU
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length of stay, and hospital mortality among the pa-
tients; symptoms of anxiety and depression measured
by the Hospital Anxiety and Depression Scale (HADS)
[15] and satisfaction measured by the Critical Care
Family Needs Inventory (CCFNI) [16] among the fam-
ily members; and prevalence of burnout syndrome
evaluated by the Maslach Burnout Inventory (MBI)
[17] among the ICU professionals. Tertiary outcomes
include need for antipsychotic agents, need for mech-
anical restraints, unplanned loss of invasive devices
(venous catheter, enteral tube, or urinary catheter),
coma-free days at day 7, and ICU-acquired pneumo-
nia, urinary tract infection, or bloodstream infection
among the patients; self-perception of involvement in
patient care among the family members; and satisfac-
tion among the ICU professionals.
Fig. 1 Study design. FFVM flexible family visitation model, ICU intensive care unit, RFVM restrictive family visitation model. All ICUs will have a
learning period within the first 15 days of phases 1 and 2. During this period, ICUs will receive the intervention (FFVM or RFVM) but will not
recruit subjects. Local investigators will use this period to adapt the ICU staff to the organizational aspects of study interventions
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
Cluster Adult medical-surgical ICUs of public and philanthropic
hospitals with at least six beds; restrictive policy of ICU
visiting hours (< 4.5 h/day)
Structural or organizational impediments to flexible family visitation,
according to the Brazilian resolution of minimal operational
requirements for ICUsa
Patients ICU patients aged ≥18 years Coma (RASS − 4 or − 5) lasting > 96 h from the moment of first
evaluation for recruitment; delirium at baseline (positive CAM-ICU);
cerebral death; aphasia; severe hearing deficit; predicted ICU length of
stay < 48 h; exclusive palliative treatment at ICU admission; unavailability
of a family member to participate in the flexible family visits; unlikelihood
to survive > 24 h; prisoner status; readmission to the ICU after enrollment
in the study
Family members Closest family member of a patient enrolled in the study Family members who do not speak Portuguese or have serious difficulty
in answering the self-applied questionnaires (e.g., due to illiteracy or
severe visual or hearing limitations); having another family member
already enrolled in the study
ICU professionals Bedside ICU professionals (physicians, nurses, nursing
technicians, and physiotherapists) who assist patients
during daytime for at least 20 h/week at the enrolled ICU
ICU professionals who have a planned leave of absence of > 15 days
during phase 1 of the study
CAM-ICU Confusion Assessment Method for the Intensive Care Unit, ICU intensive care unit, RASS Richmond Agitation-Sedation Scale
aAvailable from: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res0007_24_02_2010.html. Accessed 26 Aug 2017
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Statistical analysis plan
Overall principles
The main analysis for each outcome will be performed
at the subject level using the intention-to-treat (ITT)
principle, meaning that all participants with a recorded
outcome will be included in the analysis and will be
analyzed according to the treatment group to which they
were randomized (FFVM or RFVM), independent of ac-
tual visiting hours. Moreover, all analyses will account
for the cluster-randomized crossover design to ensure
correct type I error rates and confidence intervals (CIs).
A significance level of 0.05, adjusted for multiple com-
parisons when appropriate, will be used for all statistical
comparisons. Analysis will start once all data to dis-
charge for the last included patient have been obtained,
the database has been cleaned and locked, and the SAP
has been submitted for publication. The R Development
Core Team software will be used for analysis [18].
Handling of missing data
We anticipate minimal missing values, given that the
study variables will be determined during hospital stay
by trained researchers. Nevertheless, the coordinator
center will contact site investigators to retrieve any miss-
ing data values.
ICUs with incomplete subject recruitment (e.g., less
than 50 patients) will be included in the primary analysis
for the study outcomes considering all subjects available
in the cluster. To assess the risk of bias related to ICUs
that did not achieve the patient recruitment goal, mul-
tiple imputation techniques will be performed for the
primary outcome and presented as sensitivity analyses.
The missing values for the variables that compose the
HADS, CCFNI, and MBI will be imputed, replacing the
missing items with the mean of the answered items in
the same subscale, if at least half of that subscale has
been answered. The missing values for the variables that
compose the PREdiction of DELIRium in ICU patients
(PRE-DELIRIC) score will be imputed in a similar way
as in the original study [19]. We will assume that if a
variable is not determined, most likely the missing vari-
able has a normal or negative value (e.g., no infection,
no metabolic acidosis) or a mean value (e.g., Acute
Physiology and Chronic Health Evaluation-II [APA-
CHE-II] score) of the study population. We will not per-
form any imputation for the length of ICU visits per
patient per day.
Definition of analysis sets
At the cluster level, the ITT population includes all ran-
domized ICUs that recruited subjects, regardless of the
degree of adherence to the study interventions or
achievement of the patient recruitment goal (50 patients
per ICU). At the subject level, the ITT population
includes all participants, regardless of protocol devia-
tions. This includes patients who did not receive any
ICU visits and family members who did not visit patients
during the ICU stay, as well as patients who received
visits longer than the maximum limit of visiting hours in
both study periods (FFVM and RFVM).
Statistical analyses
Patient flow
The flow of participants will be displayed in accordance
with the Consolidated Standards of Reporting Trials
(CONSORT) flow diagram (CONSORT 2010 statement:
extension to cluster-randomized trials) [20]. This
description will include information about eligibility
criteria and follow-up losses at both cluster and sub-
ject levels.
Adherence to study interventions
The total length of visits per patient per day will be eval-
uated as the primary adherence variable to the study in-
terventions. We will consider the length of stay of all
visitors (whether family members or not) at the bedside
of an enrolled patient during the ICU stay. For analytical
purposes, we will not consider overlapping visiting hours
in the total length of visits per patient per day (i.e., only
the period in which there was at least one visitor [apart
from the number of visitors] will be considered). The
differences in the means of length of visits per patient
per day between the FFVM and the RFVM groups will
be compared using generalized estimating equations
with adjustment for the cluster effect, period effect, and
interaction between cluster and period. Additionally, we
will describe the FFVM family members’ adherence to
the website, and the healthcare professionals’ perception
of effectiveness and barriers for implementation of the
FFVM.
To assess the fidelity of FFVM implementation, we
will perform on-site monitoring visits in all participant
ICUs. During these visits, the ICU staff perception about
adherence to proposed FFVM processes will be assessed
by the coordinating center researchers using semi-struc-
tured interviews. During the FFVM period, each ICU
will be rated from 0 to 100% (with higher percentages
indicating higher levels of adherence to intended FFVM
processes) in the following domains: (1) Visiting hours -
adherence to visiting hours according to the study
protocol; (2) Dissemination - dissemination of the FFVM
to family members of ICU patients; (3) Structured meet-
ings - frequency and quality of structured meetings; (4)
Staff training - education of the ICU staff about the
FFVM procedures. The total fidelity of the FFVM imple-
mentation score represents the mean of the four evalu-
ated domains. We plan to perform sensitivity and
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exploratory analyses considering the effects of FFVM
implementation on outcomes.
Baseline characteristics
The baseline characteristics of all participants will be
presented by study arm in a table (see Table 2), but no
formal statistical hypothesis testing will be performed to
avoid unnecessary testing.
Inter-rater reliability of the CAM-ICU
Inter-rater reliability measures of the CAM-ICU will be
performed before study initiation to evaluate the quality
of assessment. In each participant ICU, we will assess
the concordance and agreement in diagnostic classifica-
tion between trained intensive care physicians (reference
diagnosis) and local outcome evaluators.
Primary outcome
All the pre-specified study outcomes are described in
Table 3. The primary outcome is the cumulative inci-
dence of delirium during ICU stay determined by the
CAM-ICU, which was validated for the Brazilian popula-
tion of critical care patients [21]. The cumulative inci-
dence of delirium is defined as the presence of delirium
(at least one positive CAM-ICU score) during the ICU
stay. The differences in the incidences of delirium be-
tween the FFVM and the RFVM groups will be com-
pared using generalized estimating equations with
adjustment for the cluster effect, period effect, and inter-
action between intervention and period and presented as
risk ratio (RR) and 95% CI.
Sensitivity analyses for the primary outcome
We aim to conduct the following sensitivity analyses for
the primary outcome to assess consistency and the risk
of bias:
1. Evaluation of study intervention effects adjusted by
the baseline risk of delirium according to the PRE-
DELIRIC score.
2. Evaluation of study intervention effects considering
the cluster adherence to FFVM implementation. In
this analysis, the study intervention effects will be
adjusted by the total fidelity of FFVM
implementation score.
3. Evaluation of study intervention effects considering
the potential confounding effect of sedation on the
delirium diagnosis. In this analysis, the study
intervention effects will be evaluated, considering
patients with positive CAM-ICU during ICU stay in
the context of Richmond Agitation-Sedation Scale
(RASS) score – 2 or − 3 as non-delirious subjects.
4. Evaluation of effects of study interventions,
considering a best plausible scenario/worst plausible
scenario imputation of outcomes among ICUs that
did not complete the patient recruitment as follows:
a) Best plausible scenario: Imputation of the lowest
study cluster/phase incidence of delirium for
missing FFVM patients and the highest study
cluster/phase incidence of delirium for missing
RFVM patients
b) Worst plausible scenario: Imputation of the
lowest study cluster/phase incidence of delirium
for missing RFVM patients and the highest
study cluster/phase incidence of delirium for
missing FFVM patients.
Subgroup analyses for the primary outcome
There will be three a priori defined subgroup analyses
for the primary endpoint: (1) effectiveness of the FFVM
vs. RFVM in ICUs according to the PRE-DELIRIC score
(patients with a predicted risk < 25%, 25–50%, 50–75%,
and > 75%); (2) effectiveness of the FFVM vs. RFVM ac-
cording to patient group (medical vs. surgical and neuro-
critical vs. non-neurocritical); and (3) effectiveness of the
FFVM vs. RFVM in ICUs according to APACHE-II
scores (≤15 vs. > 15 points). The consistency of interven-
tion effects across the above-mentioned subgroups will
be assessed by means of tests for interaction. The Bon-
ferroni correction will be applied to adjust the subgroup
analyses for multiple comparisons.
Secondary outcomes
We will use the following statistical procedures to evalu-
ate the study secondary outcomes:
1. Daily hazard of delirium: The daily hazard of
delirium will be analyzed using a joint survival
model that accounts for the treatment effect (with
adjustment for the cluster effect, period effect, and
interaction between cluster and period) on repeated
daily indicator of delirium within each patient and
terminating event (death or discharge from the
ICU) [22]. This outcome will be presented as
hazard ratio (HR) and 95% CI.
2. Any ICU-acquired infections: The differences in the
cumulative incidence of any ICU-acquired infection
between the FFVM and RFVM groups will be com-
pared using generalized estimating equations with
adjustment for the cluster effect, period effect, and
interaction between intervention and period. This
outcome will be presented as RR and 95% CI.
3. Ventilator-free days: The number of ventilator-free
days will be evaluated using the 7-day time
horizon. Ventilator-free days will be set to 0 for
patients who have died. The differences in the
mean ventilator-free days between the FFVM
and RFVM groups will be compared using
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generalized estimating equations with adjust-
ment for the cluster effect, period effect, and
interaction between intervention and period.
This outcome will be presented as mean differ-
ence (MD) and 95% CI.
4. ICU length of stay: The differences in the mean ICU
length of stay between the FFVM and RFVM
groups will be compared using generalized
estimating equations with adjustment for the
cluster effect, period effect, and interaction between
intervention and period. This outcome will be
presented as MD and 95% CI.
5. Hospital mortality: The differences in hospital
mortality rates between the FFVM and RFVM
groups will be compared using generalized
estimating equations with adjustment for the
cluster effect, period effect, and interaction
between intervention and period. This outcome
will be presented as RR and 95% CI.
6. Symptoms of anxiety and depression among family
members: The differences in the mean HADS scores
for anxiety and depression between the FFVM
and RFVM groups will be compared using
generalized estimating equations with adjustment
for the cluster effect, period effect, and
interaction between intervention and period.
These outcomes will be presented as MD and
95% CI.
7. Satisfaction among family members: The differences
in the mean CCFNI satisfaction scores between the
FFVM and RFVM groups will be compared using
generalized estimating equations with adjustment
for the cluster effect, period effect, and interaction
between intervention and period. This outcome will
be presented as MD and 95% CI.
Table 2 Baseline characteristics of study participants
FFVM RFVM
Patients
Age, years: mean (SD) xx.x (xx.x) xx.x (xx.x)
Age≥ 65 years: n/total n (%) x/x (xx.x) x/x (xx.x)
Female gender: n/total n (%) x/x (xx.x) x/x (xx.x)
Charlson comorbidity index:
median (IQR)
xx.x (xx.x-xx.x) xx.x (xx.x-xx.x)
History of dementia: n/total n (%) x/x (xx.x) x/x (xx.x)
Hazardous alcohol consumption:a
n/total n (%)
x/x (xx.x) x/x (xx.x)
ICU admission type
Medical: n/total n (%) x/x (xx.x) x/x (xx.x)
Emergency surgery: n/total n (%) x/x (xx.x) x/x (xx.x)
Elective surgery: n/total n (%) x/x (xx.x) x/x (xx.x)
PRE-DELIRIC score: mean (SD) xx.x (xx.x) xx.x (xx.x)
APACHE-II score:b mean (SD) xx.x (xx.x) xx.x (xx.x)
SOFA score:b mean (SD) xx.x (xx.x) xx.x (xx.x)
Mechanically ventilated: n/total n (%) x/x (xx.x) x/x (xx.x)
Use of vasopressor: n/total n (%) x/x (xx.x) x/x (xx.x)
Use of corticosteroids: n/total n (%) x/x (xx.x) x/x (xx.x)
Use of parenteral sedative:b
n/total n (%)
x/x (xx.x) x/x (xx.x)
Use of benzodiazepine:b n/total n (%) x/x (xx.x) x/x (xx.x)
Use of opioid:b n/total n (%) x/x (xx.x) x/x (xx.x)
Indwelling central venous catheter:
n/total n (%)
x/x (xx.x) x/x (xx.x)
Urinary catheter: n/total n (%) x/x (xx.x) x/x (xx.x)
Family members
Age, years: mean (SD) xx.x (xx.x) xx.x (xx.x)
Female gender: n/total n (%) x/x (xx.x) x/x (xx.x)
Years of education: mean (SD) xx.x (xx.x) xx.x (xx.x)
Household income, USD: median (IQR) xx.x (xx.x-xx.x) xx.x (xx.x-xx.x)
Unemployed: n/total n (%) x/x (xx.x) x/x (xx.x)
Living with care recipient: n/total n (%) x/x (xx.x) x/x (xx.x)
Surrogate decision maker: n/total n (%) x/x (xx.x) x/x(xx.x)
History of anxiety: n/total n (%) x/x (xx.x) x/x (xx.x)
History of depression: n/total n (%) x/x (xx.x) x/x (xx.x)
ICU professionals
Age, years: mean (SD) xx.x (xx.x) xx.x (xx.x)
Female gender: n/total n (%) x/x (xx.x) x/x (xx.x)
Type of ICU professional
Physician: n/total n (%) x/x (xx.x) x/x (xx.x)
Nurse: n/total n (%) x/x (xx.x) x/x (xx.x)
Nurse technician: n/total n (%) x/x (xx.x) x/x (xx.x)
Physiotherapist: n/total n (%) x/x (xx.x) x/x (xx.x)
Years of experience in ICU: mean (SD) xx.x (xx.x) xx.x (xx.x)
Table 2 Baseline characteristics of study participants (Continued)
FFVM RFVM
Hours of work per week: mean (SD) xx.x (xx.x) xx.x (xx.x)
Number of patients per professional
Physician: mean (SD) xx.x (xx.x) xx.x (xx.x)
Nurse: mean (SD) xx.x (xx.x) xx.x (xx.x)
Nurse technician: mean (SD) xx.x (xx.x) xx.x (xx.x)
Physiotherapist: mean (SD) xx.x (xx.x) xx.x (xx.x)
Burnout syndrome at baseline:c
n/total n (%)
x/x (xx.x) x/x (xx.x)
APACHE-II Acute Physiology and Chronic Health Evaluation-II, FFVM flexible
family visitation model, ICU intensive care unit, IQR interquartile range (P25–
P75), PRE-DELIRIC PREdiction of DELIRium in ICU patients, RFVM restrictive
family visitation model, SD standard deviation, SOFA Sequential Organ Failure
Assessment, USD United States dollars
aAlcohol consumption greater than or equal to 14 units per week for women
and greater than or equal to 21 units per week for men
bWithin the first 24 h of inclusion in the study
cMaslach Burnout Inventory total score > − 9
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8. Prevalence of burnout among the ICU professionals:
Burnout is defined as a cumulative MBI score
greater than − 9. The differences in the
prevalence of burnout between the FFVM and
RFVM groups will be compared using
generalized estimating equations with
adjustment for the cluster effect and baseline
MBI total scores. This outcome will be
presented as prevalence ratio and 95% CI.
Given that the main safety outcomes of the present
study are any ICU-acquired infections and burnout, we
will not adjust these outcomes for multiple comparisons.
For other secondary outcomes, the Bonferroni correction
Table 3 Study outcomes
Outcomes FFVM RFVM Type of effect
estimate
Effect estimate (CI) p valuea
Primary
Cumulative incidence of delirium:b n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Secondary
Patients
Daily hazard of delirium:b mean (SD) xx.x (xx.x) xx.x (xx.x) HR x.xx (x.xx-x.xx)** x.xx
Any ICU-acquired infection:c n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Proportion of ventilator free-days: mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)** x.xx
ICU length of stay: mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)** x.xx
Hospital mortality: n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)** x.xx
Family members
HADS anxiety score: mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)*** x.xx
HADS depression score: mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)*** x.xx
CCFNI satisfaction score: mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)*** x.xx
ICU professionals
Burnout syndrome:d n/total n (%) x/x (xx.x) x/x (xx.x) PR x.xx (x.xx-x.xx)* x.xx
Tertiary
Patients
Need for antipsychotic agents: n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Need for mechanical restraints: n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Unplanned loss of invasive devices: n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Proportion of coma-free days: mean (SD) xx.x (xx.x) xx. (xx.x) MD x.xx (x.xx-x.xx)* x.xx
ICU-acquired pneumonia:c n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
ICU-acquired UTI:c n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
ICU-acquired BSI:c n/total n (%) x/x (xx.x) x/x (xx.x) RR x.xx (x.xx-x.xx)* x.xx
Family members
Self-perception of involvement in patient care
Score:e mean (SD) xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)* x.xx
ICU professionals
Satisfaction of ICU professionals with the ICU
visiting policy score:f mean (SD)
xx.x (xx.x) xx.x (xx.x) MD x.xx (x.xx-x.xx)* x.xx
BSI bloodstream infection, CCFNI Critical Care Family Needs Inventory, CI confidence interval, FFVM flexible family visitation model, HADS Hospital Anxiety and
Depression Scale, HR hazard ratio, ICU intensive care unit, MD mean difference, PR prevalence ratio, RFVM restrictive family visitation model, RR risk ratio, SD
standard deviation, UTI urinary tract infection
aAdjusted for multiple comparisons with Bonferroni correction when appropriate
bAccording to the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) criteria
cAccording to the Centers for Disease Control and Prevention (CDC) criteria
dMaslach Burnout Inventory (MBI) total score > − 9
eThe self-perception of involvement in patient care score varies from 0 (no involvement) to 27 (maximum degree of involvement)
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will be applied to adjust the analyses for multiple compari-
sons when appropriate, taking into consideration the
number of comparisons within each population of interest
(patients, family members, and ICU professionals).
We will perform sensitivity analyses to check the
consistency of intervention effects on family members
and ICU professionals as follows:
1. Evaluation of study intervention effects on HADS
subscale scores among family members, considering
HADS scores as categorical variables with
established cutoff points (> 10 points for both
anxiety and depression subscales)
2. Evaluation of study intervention effects on HADS
subscale scores among family members adjusted by
previous history of anxiety (for anxiety HADS
subscale) and depression (for depression HADS
subscale)
3. Evaluation of study intervention effects on CCFNI
subscale domains (information, proximity,
reassurance, support, and comfort)
4. Evaluation of study intervention effects on
incidence (excluding individuals with burnout at
baseline) and prevalence of burnout among ICU
professionals, considering the following alternative
MBI criteria:
a) Alternative criteria 1: An emotional exhaustion
subscale score ≥ 27, OR a depersonalization
subscale score ≥ 10, OR a personal
accomplishment subscale score ≤ 33
b) Alternative criteria 2: An emotional exhaustion
subscale score ≥ 27, OR a depersonalization
subscale score ≥ 10
c) Alternative criteria 3: An emotional exhaustion
subscale score ≥ 27, AND a depersonalization
subscale score ≥ 10, AND a personal
accomplishment subscale score ≤ 33.
Tertiary outcomes
We will use the following statistical procedures to evalu-
ate the study tertiary outcomes:
1. Need for antipsychotic agents: The differences in the
cumulative incidence of need for antipsychotic
agents during ICU stay between the FFVM and
RFVM groups will be compared using generalized
estimating equations with adjustment for the
cluster effect, period effect, and interaction between
intervention and period. This outcome will be
presented as RR and 95% CI.
2. Need for mechanical restraints: The differences in
the cumulative incidence of need for mechanical
restraints during ICU stay between the FFVM and
RFVM groups will be compared using generalized
estimating equations with adjustment for the
cluster effect, period effect, and interaction between
intervention and period. This outcome will be
presented as RR and 95% CI.
3. Unplanned loss of invasive devices: The differences
in the cumulative incidence of any unplanned loss
of invasive devices (venous catheter, enteral tube, or
urinary catheter) during the ICU stay between the
FFVM and RFVM groups will be compared using
generalized estimating equations with adjustment
for the cluster effect, period effect, and interaction
between intervention and period. This outcome will
be presented as RR and 95% CI.
4. Coma-free days at day 7: The number of coma-free
days will be evaluated using the 7-day time horizon.
Coma-free days will be set to 0 for patients who
have died. The differences in the mean proportion
of days free of coma (RASS [23] – 4 or − 5) between
the FFVM and RFVM groups will be compared
using generalized estimating equations with adjust-
ment for the cluster effect, period effect, and inter-
action between intervention and period. This
outcome will be presented as MD and 95% CI.
5. ICU-acquired pneumonia: The differences in the
cumulative incidence of ICU-acquired pneumonia
between the FFVM and RFVM groups will be
compared using generalized estimating equations
with adjustment for the cluster effect, period ef-
fect, and interaction between intervention and
period. This outcome will be presented as RR
and 95% CI.
6. ICU-acquired urinary tract infection: The
differences in the cumulative incidence of urinary
tract infection between the FFVM and RFVM
groups will be compared using generalized
estimating equations with adjustment for the
cluster effect, period effect, and interaction between
intervention and period. This outcome will be
presented as RR and 95% CI.
7. ICU-acquired bloodstream infection: The differences
in the cumulative incidence of bloodstream
infection between the FFVM and RFVM groups
will be compared using generalized estimating
equations with adjustment for the cluster effect,
period effect, and interaction between intervention
and period. This outcome will be presented as RR
and 95% CI.
8. Self-perception of involvement in patient care among
the family members: The self-perception of involve-
ment in patient care will be evaluated using a score
developed for the present study, which is composed
of 9 questions related to the self-perception of in-
volvement of the family member in the care of the
patient in the following domains: (1) re-orientation
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activities, (2) pain control, (3) mobilization, (4) feed-
ing, (5) hygiene, (6) emotional support, (7) helping
patients to interpret ICU staff orientations, (8) help-
ing the ICU professionals to understand patient
needs, and (9) helping to create a patient-friendly
environment in the patient room. The score of each
question ranges from 0 (never involved in the activ-
ity) to 3 (very frequently involved in the activity).
The total score, which varies from 0 (no involve-
ment) to 27 (maximum degree of involvement), will
be obtained by the sum of the scores of each ques-
tion. The differences in the mean total scores of
self-perception of involvement in patient care be-
tween the FFVM and RFVM groups will be com-
pared using generalized estimating equations with
adjustment for the cluster effect, period effect, and
interaction between intervention and period. This
outcome will be presented as MD and 95% CI.
9. Satisfaction among ICU professionals: The
satisfaction of ICU professionals will be evaluated
through the score of the following question: Are
you satisfied with the current visiting policy of your
ICU? The responses to this 5-option Likert scale
question may be one of the following: 0 - unsatis-
fied, 1- somewhat dissatisfied, 2 - indifferent, 3 -
somewhat satisfied, 4 - very satisfied. The differ-
ences in the mean score values between the FFVM
and RFVM groups will be compared using general-
ized estimating equations with adjustment for the
cluster effect. This outcome will be presented as
MD and 95% CI.
No adjustment for multiple comparisons will be made
for tertiary outcomes. Therefore, the results of tertiary
outcomes should be considered exploratory.
Differences between the study protocol and statistical
analysis plan
There are no differences between the study protocol and
this SAP in relation to the proposed outcomes or statis-
tical procedures.
Discussion and trial status
In this SAP, we present the statistical procedures that
will allow the comparison of effectiveness and safety out-
comes between the FFVM and RFVM in the ICU Visits
Study. The present publication aims to avoid risks of
outcome reporting bias and data-driven results and pro-
vide guidance for statistical analysis for future studies in
this field. As of March 2018, 40 ICUs were randomized.
Currently, 1591 patients, 1192 family members, and 829
ICU professionals were included in the study. We expect
that the recruitment of subjects will be completed in
June 2018.
Abbreviations
APACHE-II: Acute Physiology and Chronic Health Evaluation-II; BSI: Bloodstream
infection; CAM-ICU: Confusion Assessment Method for the Intensive Care Unit;
CCFNI: Critical Care Family Needs Inventory; CDC: Centers for Disease Control
and Prevention; CI: Confidence interval; CONSORT: Consolidated Standards of
Reporting Trials; FFVM: Flexible family visitation model; HADS: Hospital Anxiety
and Depression Scale; HR: Hazard ratio; ICU: Intensive care unit; IQR: Interquartile
range; MBI: Maslach Burnout Inventory; MD: Mean difference; PR: Prevalence
ratio; PRE-DELIRIC: PREdiction of DELIRium in ICU patients; RASS: Richmond
Agitation-Sedation Scale; RFVM: Restrictive family visitation model; RR: Risk ratio;
SAP: Statistical analysis plan; SD: Standard deviation; SOFA: Sequential Organ
Failure Assessment; USD: United States dollars; UTI: Urinary tract infection
Acknowledgements
The authors thank Hospital Moinhos de Vento and the Brazilian Ministry of
Health for their support in conducting the study.
Funding
The present study was funded by the Brazilian Ministry of Health through
the Program of Institutional Development of the Brazilian Unified Health
System (PROADI-SUS). The trial is coordinated by Hospital Moinhos de Vento
and endorsed by the Brazilian Research in Intensive Care Network (BRICNet).
Availability of data and materials
The datasets used and/or analyzed during the current study will be available
from the corresponding author on reasonable request.
Authors’ contributions
DS, CT, CCR, RK, FB, ABC, LCPA, FRM, JIS, JASP, RBM, LPD, NB, MF, and RGR
were involved in the conception and design of the SAP. DS, CT, and RGR
drafted the manuscript. DS (fisrt author), CT, CCR, RK, MMSS, RMM, MGB, DBS,
TSRH, CSE, DS, DMO, RWJ, FAB, ABC, LCPA, FRM, JIS, JASP, RBM, LPD, NBS,
MF, and RGR revised and approved the final manuscript.
Ethics approval and consent to participate
This study will be conducted according to Resolution No. 466/12 of the
Brazilian National Health Council (http://bvsms.saude.gov.br/bvs/saudelegis/
cns/2013/res0466_12_12_2012.html). The present study protocol version
(version 3, from 22 February 2017) has been approved by the research ethics
committee of the coordinating site (approval No. CAAE 57717516.3.1001.5330)
and the research ethics committees of all participating institutions. The need for
patients’ written informed consent was waived in 37 of 40 participating ICUs,
because the standard of care encompasses both study interventions. In 3 of 40
ICUs informed consent will be required for patients or proxies. Informed




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Research Projects Office, Hospital Moinhos de Vento (HMV), Rua Ramiro
Barcelos, 910, Moinhos de Vento, Porto Alegre, RS 90035-001, Brazil.
2Intensive Care Unit, HMV. Rua Ramiro Barcelos, 910, Moinhos de Vento,
Porto Alegre, RS 90035-001, Brazil. 3Department of Critical Care, Instituto D’Or
de Pesquisa e Ensino (IDOR), Rua Diniz Cordeiro, 30, Botafogo, Rio de Janeiro,
RJ 22281-100, Brazil. 4HCor Research Institute, Rua Abílio Soares, 250, Paraíso,
São Paulo, SP 04005-909, Brazil. 5Intensive Care Unit, Hospital Sírio-Libanês,
Rua Dona Adma Jafet, 91, Bela Vista, São Paulo, SP 01308-050, Brazil.
6Department of Anesthesiology, Pain and Intensive Care, Universidade
Federal de São Paulo (UNIFESP), Rua Napoleão de Barros 737, Vila
Clementino, São Paulo, SP 04024-900, Brazil. 7Intensive Care Unit, Hospital de
Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Santa Cecília,
Porto Alegre, RS 90035-903, Brazil. 8Department of Internal Medicine, School
of Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre
Sganzerla et al. Trials          (2018) 19:636 Page 9 of 10
(UFCSPA), Rua Sarmento Leite, 245, Centro Histórico, Porto Alegre, RS
90050-170, Brazil. 9Institute for Education and Research, HMV, Rua Ramiro
Barcelos, 910, Moinhos de Vento, Porto Alegre, RS 90035-001, Brazil.
Received: 29 May 2018 Accepted: 20 October 2018
References
1. Gerritsen RT, Hartog CS, Curtis JR. New developments in the provision of
family-centered care in the intensive care unit. Intensive Care Med. 2017;43:
550–3.
2. Goldfarb MJ, Bibas L, Bartlett V, Jones H, Khan N. Outcomes of patient- and
family-centered care interventions in the ICU: a systematic review and
meta-analysis. Crit Care Med. 2017;45:1751–61.
3. Rosa RG, Tonietto TF, da Silva DB, Gutierres FA, Ascoli AM, Madeira LC, et al.
Effectiveness and safety of an extended ICU visitation model for delirium
prevention: a before and after study. Crit Care Med. 2017;45:1660–7.
4. Westphal GA, Moerschberger MS, Vollmann DD, Inácio AC, Machado MC,
Sperotto G, et al. Effect of a 24-h extended visiting policy on delirium in
critically ill patients. Intensive Care Med. 2018;44:968–70. https://doi.org/10.
1007/s00134-018-5153-5 [Epub ahead of print].
5. Nassar Junior AP, Besen BAMP, Robinson CC, Falavigna M, Teixeira C, Rosa
RG. Flexible versus restrictive visiting policies in ICUs: a systematic review
and meta-analysis. Crit Care Med. 2018;46:1175–80. https://doi.org/10.1097/
CCM.0000000000003155 [Epub ahead of print].
6. Ramos FJ, Fumis RR, de Azevedo LC, Schettino G. Intensive care unit
visitation policies in Brazil: a multicenter survey. Rev Bras Ter Intensiva. 2014;
26:339–46.
7. Garrouste-Orgeas M, Vinatier I, Tabah A, Misset B, Timsit JF. Reappraisal of
visiting policies and procedures of patient’s family information in 188
French ICUs: a report of the Outcomerea Research Group. Ann Intensive
Care. 2016;6:82.
8. Noordermeer K, Rijpstra TA, Newhall D, Pelle AJ, van der Meer NJ. Visiting
policies in the adult intensive care units in the Netherlands: survey among
ICU directors. ISRN Critical Care. 2013;137045:1–6.
9. Lee MD, Friedenberg AS, Mukpo DH, Conray K, Palmisciano A, Levy MM.
Visiting hours policies in New England intensive care units: strategies for
improvement. Crit Care Med. 2007;35:497–501.
10. Rosa RG, Falavigna M, Robinson CC, da Silva DB, Kochhann R, de Moura RM,
et al. Study protocol to assess the effectiveness and safety of a flexible
family visitation model for delirium prevention in adult intensive care units:
a cluster-randomised, crossover trial (The ICU Visits Study). BMJ Open. 2018;
8:e021193.
11. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, et al. Evaluation of
delirium in critically ill patients: validation of the Confusion Assessment
Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29:1370–9.
12. Centers for Disease Control and Prevention. Bloodstream Infection Event
(Central Line-Associated Bloodstream Infection and non-central line-
associated Bloodstream Infection). 2017. https://www.cdc.gov/nhsn/pdfs/
pscmanual/4psc_clabscurrent.pdf. Accessed 14 Jun 2017.
13. Centers for Disease Control and Prevention. Pneumonia (Ventilator-
associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event.
2017. https://www.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf.
Accessed 14 Jun 2017.
14. Centers for Disease Control and Prevention. Urinary Tract Infection
(Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-
Associated Urinary Tract Infection [UTI]) and Other Urinary System Infection
[USI] Events. 2017. https://www.cdc.gov/nhsn/pdfs/pscManual/7pscCauticurrent.
pdf. Accessed 14 Jun 2017.
15. Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WA. Mood disorders
among medical in-patients: a validation study of the hospital anxiety and
depression scale (HAD). Rev Saude Publica. 1995;29:355–63.
16. Fumis RR, Nishimoto IN, Deheinzelin D. Measuring satisfaction in family
members of critically ill cancer patients in Brazil. Intensive Care Med. 2006;
32:124–8.
17. Campos JA, Maroco J. Maslach Burnout Inventory - Student Survey:
Portugal-Brazil cross-cultural adaptation. Rev Saude Publica. 2012;46:816–24.
18. R Development Core Team. R: A language and environment for statistical
computing. Vienna: R Foundation for Statistical Computing; 2016. https://
www.R-project.org/. Accessed 14 Jun 2017
19. van den Boogaard M, Pickkers P, Slooter AJ, Kuiper MA, Spronk PE, van der
Voort PH, et al. Development and validation of PRE-DELIRIC (PREdiction of
DELIRium in ICu patients) delirium prediction model for intensive care
patients: observational multicentre study. BMJ. 2012;344:e420.
20. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement:
extension to cluster randomised trials. BMJ. 2012;345:e5661.
21. Gusmao-Flores D, Salluh JI, dal-Pizzol F, Santana LR, Lins RM, Lemos PP, et
al. Validity and reliability of the Brazilian-Portuguese version of three tools to
diagnose delirium: CAM-ICU, CAM-ICU Flowsheet and ICDSC. Crit Care.
2011;15(Suppl 2):P50.
22. Colantuoni E, Dinglas VD, Ely EW, Hopkins RO, Needham DM. Statistical
methods for evaluating delirium in the ICU. Lancet Repir Med. 2016;4(7):
534–6.
23. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O'Neal PV, Keane KA, et al. The
Richmond Agitation-Sedation Scale: validity and reliability in adult intensive
care unit patients. Am J Respir Crit Care Med. 2002;166:1338–44.
Sganzerla et al. Trials          (2018) 19:636 Page 10 of 10
